Heather Wenberg, BSN, RN, OCN, is the regional director of nursing at American Oncology Network.
Subcutaneous Daratumumab Requires Less Time, Premed in Multiple Myeloma
Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says Heather Wenberg, BSN, RN, OCN.
Injection Time Can Encourage Bonding During Myeloma Care
The extended injection time for subcutaneous daratumumab in those with myeloma can serve as an opportunity for oncology nurses to check in with patients.
Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid Tumors
PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert
Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL
Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts